Cargando…
VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions
PURPOSE: The aim of this retrospective study is to evaluate patient profile, feasibility, and acute toxicity of RadioTherapy (RT) delivered by VERO® in the first 20 months of clinical activity. METHODS: Inclusion criteria: 1) adult patients; 2) limited volume cancer (M0 or oligometastatic); 3) small...
Autores principales: | Orecchia, R, Surgo, A, Muto, M, Ferrari, A, Piperno, G, Gerardi, MA, Comi, S, Garibaldi, C, Ciardo, D, Bazani, A, Golino, F, Pansini, F, Fodor, C, Romanelli, P, Maestri, D, Scroffi, V, Mazza, S, Jereczek-Fossa, BA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045299/ https://www.ncbi.nlm.nih.gov/pubmed/27729942 http://dx.doi.org/10.3332/ecancer.2016.677 |
Ejemplares similares
-
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience
por: Gerardi, Marianna A., et al.
Publicado: (2016) -
Recent advances in radiation oncology
por: Garibaldi, Cristina, et al.
Publicado: (2017) -
The emerging role of radiation therapists in the contouring of organs at risk in radiotherapy: analysis of inter-observer variability with radiation oncologists for the chest and upper abdomen
por: Arculeo, Simona, et al.
Publicado: (2020) -
Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma
por: Vavassori, Andrea, et al.
Publicado: (2019) -
Re‐evaluation of thaumatin (E 957) as food additive
por: Younes, Maged, et al.
Publicado: (2021)